Whole Brain Imaging with Serial Two-Photon Tomography
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Imaging entire mouse brains at submicron resolution has historically been a challenging undertaking and largely confined to the province of dedicated atlasing initiatives. This has limited systematic investigations into important areas of neuroscience, such as neural circuits, brain mapping and neurodegeneration. In this article, we describe in detail Serial Two-Photon (STP) tomography, a robust, reliable method for imaging entire brains with histological detail. We provide examples of how the basic methodology can be extended to other imaging modalities, such as Optical Coherence Tomography (OCT), in order to provide unique contrast mechanisms. Furthermore, we provide a survey of the research that STP tomography has enabled in the field of neuroscience, provide examples of how this technology enables quantitative whole brain studies, and discuss the current limitations of STP tomography-based approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What we can do and what we cannot do with fMRI
Logothetis, N. K. (2008) · Nature · doi:10.1038/nature06976 · Cited by 3,612 · cited 2×
“In order to take advantage of systemic administration of AAVs newly identified BBB penetrant AAV serotypes must be extensively profiled to protect against unwanted side effects resulting from nonspecific tissue distribution.”
BackgroundA mesoscale connectome of the mouse brain
Oh, S. W., Harris, J. A., Ng, L., Winslow, B., Cain, N., Mihalas, S., Wang, Q., Lau, C., Kuan, L., Henry, A. M., et al. (2014) · Nature · doi:10.1038/nature13186 · Cited by 2,612 · cited 3×
“If full 3D tissue reconstruction is desired, volumetric stacks extending past the sectioning depth can be acquired, stitching successive volumes together axially to form full 3D images. samples, including behavioral conditioning paradigms or systematic investigations like the Allen Mouse Brain Connectivity Atlas, whic…”
BackgroundResultSerial Block-Face Scanning Electron Microscopy to Reconstruct Three-Dimensional Tissue Nanostructure
Denk, W., & Horstmann, H. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020329 · Cited by 1,644 · cited 2×
“…of tissue components; computeraided image analyses quantitatively explore relationships between the various components and makes it possible to handle the vast amounts of data that is generated (Klunk et al., 2002; Dean and Palmer, 2014; Piccinini and Shagrir, 2014; Jordan and Mitchell,…”
BackgroundMethodIntravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 2×
“Gene Therapy The promise afforded by advances in gene therapy has again placed AAVs at the forefront of drug discovery for neurological diseases (Foust et al., 2009; Bourdenx et al., 2014).”
BackgroundRichardson, D. S., & Lichtman, J. W. (2015) · Cell · doi:10.1016/j.cell.2015.06.067 · Cited by 1,095 · cited 1×
“Thus, mechanically sectioning the tissue remains the best option to maintain sufficient resolution and contrast throughout the tissue volume (Richardson and Lichtman, 2015; Albanese and Chung, 2016; Economo et al., 2016).”
BackgroundTherapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893 · cited 3×
“However, while the repertoire of AAV serotypes demonstrating BBB penetrance has significantly expanded (Bourdenx et al., 2014), most clinical applications have been limited to the AAV2 (Mingozzi and High, 2011).”
BackgroundMeasurement of Immediate‐Early Gene Activation‐ c‐fos and Beyond
Kovács, K. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01734.x · Cited by 493
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., & Aminoff, M. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c29356 · Cited by 445 · cited 1×
“For instance, in Parkinson’s disease, several gene therapy clinical trials have been tested using local injections of AAV2 into the striatum and subthalamic nucleus of PD patients, in hopes of maintaining or restoring dopaminergic neuron function (Eberling et al., 2008; Christine et al., 2009).”
BackgroundKlunk, W. E., Bacskai, B. J., Mathis, C. A., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Debnath, M. L., Holt, D. P., Wang, Y., & Hyman, B. T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.797 · Cited by 412
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
Eberling, J. L., Jagust, W. J., Christine, C. W., Starr, P., Larson, P., Bankiewicz, K. S., & Aminoff, M. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312381.29287.ff · Cited by 370
Cited by
Whitesell, J. D., Buckley, A. R., Knox, J. E., Kuan, L., Graddis, N., Pelos, A., Mukora, A., Wakeman, W., Bohn, P., Ho, A., et al. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24555 · Cited by 99
Microstructural imaging in the spinal cord and validation strategies
Cohen-Adad, J. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.04.009 · Cited by 50
On the Usage of Brain Atlases in Neuroimaging Research
Hess, A., Hinz, R., Keliris, G. A., & Boehm-Sturm, P. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1259-y · Cited by 30
Steinman, J., Cahill, L. S., Koletar, M. M., Stefanovic, B., & Sled, J. G. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116101 · Cited by 24
Metadata
- Authors
- Amato, S. P., Pan, F., Schwartz, J., & Ragan, T. M.
- Venue
- Frontiers in Neuroanatomy
- Publisher
- Frontiers Media SA
- Published
- 2016-03-22
- Volume
- 10
- Pages
- 31-31
- ISSN
- 1662-5129 (ISSN-L)
- OpenAlex
- W2333084155
- Cited by
- 67
- References
- 12
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Whole Brain Imaging with Serial Two-Photon Tomography. https://app.cochat.ai/papers/10.3389/fnana.2016.00031
- The paper
- Amato, S. P., Pan, F., Schwartz, J., & Ragan, T. M. (2016). Whole Brain Imaging with Serial Two-Photon Tomography. Frontiers in Neuroanatomy. https://doi.org/10.3389/fnana.2016.00031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.